HPV vaccine does not appear to be effective for treating pre-existing HPV infection
on for this age group the ACIP also considered safety and immunogenicity data and programmatic issues. While there are safety and immunogenicity data in this age group through 18 months as well as studies indicating good protection through 5 years after vaccination among older women as for other new vaccines data on long-term efficacy are limited. Data on longer-term efficacy will be important
Date:8/14/2007